We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · January 05, 2017

Efficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Efficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results From the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola Ça Suffit!)
Lancet 2016 Dec 22;[EPub Ahead of Print], AM Henao-Restrepo, A Camacho, IM Longini, CH Watson, WJ Edmunds, M Egger, MW Carroll, NE Dean, I Diatta, M Doumbia, B Draguez, S Duraffour, G Enwere, R Grais, S Gunther, PS Gsell, S Hossmann, SV Watle, MK Kondé, S Kéïta, S Kone, E Kuisma, MM Levine, S Mandal, T Mauget, G Norheim, X Riveros, A Soumah, S Trelle, AS Vicari, JA Røttingen, MP Kieny

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading